ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1384	National Cancer Institute	Html	en	Breast Cancer Treatment and Pregnancy (PDQ®)–Health Professional Version	Breast cancer is the most common cancer in pregnant women and can be hard to detect because of changes in the breast that occur with pregnancy. Learn about the incidence, diagnosis, and treatment of breast cancer during pregnancy, as well as the effect a history of breast cancer can have on future pregnancies and children.	lactating women 0.489293 pregnant patients 0.451652 maternal risk factors. 0.471964 excisional biopsy 0.436656 unknown mapping methods 0.465613 bone scan delivers 0.472975 pregnant breast cancer 0.551836 endocrine therapy 0.452933 pregnancy study group 0.497501 pregnant women 0.605166 children 0.438022 breast examination 0.440643 mean gestational age 0.472372 gestational age 0.685559 bilateral ureteral reflux 0.456905 little risk 0.40821 congenital abnormalities 0.48754 fetal radiation exposure. 0.54026 patients 0.456683 natural tenderness 0.408433 trimester 0.554851 routine prenatal examination 0.479476 case reports 0.468475 age-matched population. 0.40591	breast preservation. 0.427847 palpable mass 0.407409 normal cardiac findings. 0.453276 fine-needle aspiration 0.408992 magnetic resonance imaging 0.471266 radiation delivered. 0.440906 harmful scatter radiation 0.506942 nonpregnant patients 0.413103 smaller retrospective series 0.451832 radiation exposure 0.619234 suspicious physical findings. 0.49123 prospective single-arm study 0.468244 multicenter case-control study 0.482053 limited prospective data 0.465326 Foley catheter drainage 0.474023 sentinel node biopsy 0.622944 breast cancer 0.95807 systematic review 0.463958 trastuzumab administration 0.445663 retrospective case series 0.470132 cancer treatment-exposed group 0.487835 methylene blue dye 0.469549 core biopsy 0.431953 postpartum radiation therapy 0.508953	CLICK HERE
1508	National Cancer Institute	Html	en	AIDS-Related Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.	bone marrow involvement. 0.64582 San Francisco Department 0.640611 newly diagnosed AIDS 0.661519 classical HL 0.664649 AIDS-related PCNSL 0.673507 cART era 0.702538 systemic lymphoma 0.656424 Epstein-Barr virus 0.637436 2-year overall survival 0.64874 HIV-infected homosexual men 0.643658 worse median survival 0.6947 median overall survival 0.678448 non-Hodgkin lymphomas 0.64597 patients 0.884787 Burkitt lymphoma 0.731575 certain opportunistic infections 0.656652 AIDS-related lymphomas 0.747647 HIV-associated HL presents 0.728404 immunodeficiency virus type 0.664684 large cell/immunoblastic lymphoma 0.706838 active antiretroviral therapy 0.65426 additional epidemiologic studies 0.641093 AIDS-related lymphoma 0.689324 large B-cell lymphoma 0.712331	human immunodeficiency virus 0.98371 OS rate 0.662052 et al. 0.677948 antiretroviral therapy 0.808834 opportunistic infections 0.717427 AIDS-related CNS infections 0.686364 Hodgkin lymphoma 0.73104 non–HIV-associated HL 0.666192 noncleaved cell lymphoma 0.70352 lymphoma 0.790941 Clin Oncol 0.63995 classical Hodgkin lymphoma 0.712756 lymphocyte-depleted HL 0.665739 anal cancer 0.646441 bone marrow 0.855918 median survival time 0.884464 newly diagnosed HL 0.722202 immunodeficiency virus results 0.662299 primary effusion lymphoma 0.746053 nervous system lymphoma 0.644768 previously diagnosed AIDS 0.751325 immunoblastic non-Hodgkin lymphoma 0.707885 HIV infection 0.640421 cerebral toxoplasmosis 0.679755	CLICK HERE
1626	National Cancer Institute	Html	en	Liver (Hepatocellular) Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.	HCV infections 0.396129 Long-term iron depletion 0.434578 CHC patients 0.518812 HCC incidence 0.527647 considerable progress 0.374353 viral infections 0.460226 ethnic groups 0.382981 similar symptoms 0.373956 Hepatitis B virus 0.560635 greater risk 0.376989 iron depletion 0.497763 severe liver fibrosis 0.434898 HCC 0.672571 hepatitis C. 0.612223 Age-standardized incidence rates 0.469423 cancer mortality worldwide 0.478797 iron depletion therapy 0.43959 mild iron deficiency 0.431003 monthly maintenance phlebotomy 0.440922 hepatitis B infection 0.565315 global public health 0.444379 chronic disease 0.39654 long-term liver problems 0.441516 main causes 0.378422 new cases 0.385753	hepatocellular cancer 0.460335 HCV-related chronic hepatitis 0.651512 white men. 0.38629 United States 0.759498 long duration 0.376762 natural history 0.377715 geographic region. 0.381817 common cancer 0.445599 North America. 0.386623 hepatitis C virus 0.560378 underwent weekly phlebotomy 0.443537 cancer mortality worldwide. 0.479228 viral hepatitis 0.542971 higher risk 0.375814 biopsy-proven CHC patients 0.468182 distinct male preponderance 0.461131 CHC account 0.409155 chronic hepatitis 0.921284 frequent viral infections 0.45994 previous interferon 0.372717 liver cancer 0.397286 acute infections 0.383971 serum alanine aminotransferase 0.429339 Asians/Pacific Islanders 0.385493	CLICK HERE
1699	National Cancer Institute	Html	en	Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gestational trophoblastic disease.	cancer treatment 0.629773 distant parts 0.609964 gestational trophoblastic tumor 0.634863 ongoing clinical trials 0.615611 gestational trophoblastic disease 0.980639 body 0.6821 PDQ cancer information 0.678639 clinical trial search 0.680326 uterus 0.71162 clinical trials 0.968129 High blood pressure 0.608092 placental-site trophoblastic tumor 0.671479 cancer information summary 0.644738 invasive mole 0.617754 clinical trial 0.770607 invasive moles 0.613464 patients 0.609009 hydatidiform mole 0.658477 blood vessels 0.619408 treatment clinical trial 0.593684 trophoblastic tumor 0.676329 NCI PDQ cancer 0.598837 molar pregnancy 0.617282 gestational trophoblastic neoplasia 0.841921 radiation therapy 0.657265	Treatment Editorial Board 0.593622 General information 0.600341 treatment 0.803629 hydatidiform moles 0.589637 NCI-supported cancer 0.614308 cancer cells 0.665812 Cancer Information Service 0.589805 tumor forms 0.590743 normal pregnancy 0.631307 treatment clinical trials 0.63304 National Cancer Institute 0.644064 new treatment 0.629182 epithelioid trophoblastic tumors 0.658247 epithelioid trophoblastic tumor 0.673512 Trophoblastic Disease Treatment 0.618342 combination chemotherapy 0.60364 blood 0.654851 gestational trophoblastic tumors 0.669932 cancer clinical trials 0.694698 human chorionic gonadotropin 0.796334 tumor 0.770797 cancer 0.954041 appropriate cancer treatment 0.604611 standard treatment 0.593708	CLICK HERE
1750	National Cancer Institute	Html	null	BRCA1 and BRCA2: Cancer Risk and Genetic Testing	A fact sheet about the BRCA1 and BRCA2 genes, what to do if a person tests positive for alterations in one of these genes, and consequences of genetic testing.			CLICK HERE
1961	National Cancer Institute	Html	es	Tratamiento del cáncer de vulva (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vulva.	estadios iva 0.421275 rayo angosto 0.420414 Vulvar Cancer 0.417101 siguientes procedimientos 0.541792 IB.Ampliar Tamaños 0.422647 estadio iv 0.58857 tinte circula 0.426876 rayo x 0.423229 vulva recidivante 0.648879 siguientes aspectos 0.430874 estadio ii 0.610359 ganglios linfáticos.ampliar milímetros 0.472722 estadios ia 0.421501 ganglio linfático centinela 0.970223 vía oral 0.418459 rayos x 0.422238 estadio ivb 0.479845 estadio ib 0.448972	estadio ia 0.448137 enlace drugs approved 0.431501 Vulvectomía tegumentaria 0.424681 National Cancer Institute 0.419214 estadios iiia 0.423069 Instituto Nacional 0.434203 estadio iiia 0.448591 PDQ Tratamiento 0.437982 estadio iiic 0.447516 estadio iva cáncer 0.523085 Physician Data Query 0.469403 prueba pap 0.425219 lápiz mide 0.424089 estadio iii 0.594503 vulva evoluciona 0.623314 vulva causa efectos 0.543623 siguientes pruebas 0.431957 siguientes estadios 0.427405	CLICK HERE
2957	National Cancer Institute	Html	en	Explore Medications	Learn about medications to help you quit smoking, including nicotine replacement therapy. Using these medicines can double your chances of quitting smoking for good.	NRT products 0.859007 different ways 0.525165 Vet 0.449372 commonly used family 0.643542 quit methods 0.557053 smoking strategy 0.533582 program 0.442703 medical experts 0.529864 body 0.424396 urge 0.474392 good 0.428456 research 0.426164 NRT 0.961664 certain NRT products 0.832637 cigarette cravings 0.560385 variety 0.424404	helpful tools smokers 0.636828 best chance 0.510548 text 0.442731 strategies 0.42364 Nicotine replacement therapy 0.674382 Mom 0.450701 people 0.484671 Doctors 0.423874 quit smoking medications 0.715967 effects 0.426308 withdrawal feelings 0.696466 chances 0.469669 dangerous chemicals 0.532355 cigarettes 0.427284 main addictive substance 0.61447	CLICK HERE
3449	National Cancer Institute	Html	es	Prevención del cáncer de ano (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de ano y sobre las investigaciones dirigidas a prevenir esta enfermedad.	preservativos protege 0.348482 siguientes factores 0.806347 suficientes estudios 0.342762 voluntarios sanos 0.341993 Physician Data Query 0.494379 fuerte factor 0.356186 Estados Unidos 0.640069 suficiente ejercicio 0.356939 cuello uterino 0.913633	prevención revisa 0.348763 PDQ Prevención 0.389253 largo plazo 0.344404 principal factor 0.355962 sexo anal 0.379093 National Cancer Institute 0.350168 siguientes riesgos 0.341101 siguientes prácticas 0.360133 Instituto Nacional 0.391026	CLICK HERE
16860	National Cancer Institute	Html	en	Transfer of a Grant	NIH prior approval is required for the transfer of a grant. Learn more about transferring a cancer research grant from one entity to another.	Acceptance 0.529837 activity 0.531251 transfer application 0.649492 new sponsoring organization 0.793162 Administrative Requirements—Management Systems 0.769594 recipient organization 0.934277 transfer process 0.658996 title 0.525452 international organizations 0.665292 Council 0.528447 new organization 0.642366 individual fellowship 0.65473 Board 0.528424 review 0.526201 statement 0.525862 construction grants 0.679908 successor-in-interest 0.526801	NIH grants 0.781915 additional information 0.652018 IC’s Advisory 0.671293 legal entity 0.680631 Procedures—Property Management 0.646355 approved project period 0.819223 grant funds 0.679599 approval 0.582201 change 0.740921 grant-supported project 0.674314 equipment 0.551691 right 0.525484 foreign institutions 0.665492 administrative responsibility 0.686375 performance 0.531018 recipient’s relinquishment 0.812185 fellow’s department 0.658483	CLICK HERE
17220	National Cancer Institute	Html	es	TMIST (Estudio de detección de cáncer con imágenes mamográficas de tomosíntesis)	TMIST es un estudio aleatorizado de exámenes de detección de cáncer de seno que compara dos tipos de mamografía digital aprobados por la FDA, la mamografía digital (2-D) convencional con una tecnología más nueva llamada mamografía de tomosíntesis (3-D).	banco de tejido para investigaciones 0.91708 2D toma imágenes 0.651864 seno o cambios 0.988947 imagen plana. Las imágenes 0.847588 Tienen antecedentes familiares 0.628035	Cáncer ECOG-ACRIN 0.605173 estudio tmist 0.926327 pruebas genéticas o cambios 0.786757 Estados Unidos 0.661646	CLICK HERE